S100B and Alzheimer disease: Lastly, by using S100B-overexpressing transgenic and S100B knockout mice intracerebroventricular injected with human oligomeric Aβ1−42, it was established a relationship between S100B levels and susceptibility to AD-relevant neuroinflammation and neuronal dysfunction.